Table 2.
Treatment-emergent AEs reported in more than 5% of patients (intent-to-treat population)
| Preferred term | N = 189, n (%) |
|---|---|
| Any AE | 182 (96.3) |
| Penile hematoma∗ | 114 (60.3) |
| Penile pain | 64 (33.9) |
| Penile swelling | 57 (30.2) |
| Penile edema | 46 (24.3) |
| Penile hemorrhage | 39 (20.6) |
| Injection-site hematoma | 35 (18.5) |
| Injection-site pain | 32 (16.9) |
| Injection-site hemorrhage | 21 (11.1) |
| Injection-site swelling | 20 (10.6) |
| Contusion | 17 (9.0) |
AE = adverse event.
Most (95.9%) were identified as bruising.